PCRX

Pacira Pharmaceuticals, Inc.

1 day chart

About PCRX

Pacira BioSciences, Inc. is a holding company for Pacira Pharmaceuticals, Inc. The Company is engaged in advancing a pipeline of products across a range of therapeutic areas that include acute postsurgical pain; acute and chronic osteoarthritis (OA), pain of the knee; low back and other areas; spasticity and stellate ganglion block of the sympathetic nerves. The company is developing interventions to address debilitating conditions involving the sympathetic nervous system. The Company's non-opioid treatments include EXPAREL (bupivacaine liposome injectable suspension), which is a long-acting, local analgesic; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), which is an extended-release, intra-articular, corticosteroid injection indicated for OA knee pain, and Iovera, which is a novel handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Buy US stocks in Australia starting with PCRX. Open an account and start investing today!

Market Capitalisation

$1.85B

Price-earnings ratio

Dividend yield

0.00%

Volume

High today

$41.44

Low today

$39.80

Open price

$0.00

52-week high

$82.16

52-week low

$35.35

PCRX FAQs

How much is one share of Pacira Pharmaceuticals, Inc.?

One share of Pacira Pharmaceuticals, Inc. is valued at $40.20.

What is the ticker symbol for Pacira Pharmaceuticals, Inc.?

The ticker symbol for Pacira Pharmaceuticals, Inc. is PCRX.

How do I buy PCRX shares in Australia?

To buy PCRX stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in PCRX

What is the 52-week high for Pacira Pharmaceuticals, Inc. stock?

The Pacira Pharmaceuticals, Inc. 52-week high stock price is $82.16.

What is the 52-week low for Pacira Pharmaceuticals, Inc. stock?

The Pacira Pharmaceuticals, Inc. 52-week low stock price is $35.35.

What is the market capitalisation of Pacira Pharmaceuticals, Inc. PCRX?

As of 31/03/2023 Pacira Pharmaceuticals, Inc. has a market cap of $1.8B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.